Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
80.25    -22.45 (-21.86%)
Bid:
80.50
Ask:
80.95
Spread: 0.45 (0.559%)
Market Cap: £297.86m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Directorate change

11 Dec 2025 07:01

RNS Number : 0966L
RWS Holdings PLC
11 December 2025
Β 

11 December 2025

RWS Holdings plc

Directorate Change

RWS Holdings plcΒ ("RWS", the "Company"), a global AI solutions company, today announces that Julie Southern, Chairman and David Clayton, Senior Independent Director ("SID"), have informed the Board of their intention to step down as Chairman and SID respectively and as directors of the Company .

During her tenure, Julie has overseen the strengthening of the Board with the appointments of Paul Abbott and Graham Cooke which extended the Board to five independent non-executive directors alongside appointing, and transitioning to, new executive leadership and supporting the development of the Group's new strategy.

With this strengthened Board in place, David Clayton has decided to step down following his 16 years as a Board member of SDL and RWS.

Julie and David will step down with effect from 31 December 2025. Andrew Brode and Gordon Stuart become interim Chairman and interim SID respectively, whilst a search for a successor for Julie is undertaken. The outcome of that process will be announced in due course.

Julie Southern, Chairman, said:

"Having joined the Board at a pivotal time in the Group's development, RWS now has an exciting AI-led strategy in place, led by a new technology-focused CEO and supported by a strengthened Board. With these firm foundations in place, it is a good time to hand the reins over to a new Chair as RWS embarks on its next chapter."

Benjamin Faes, Chief Executive Officer, said:

"Our thanks go to Julie and David for their significant contributions to RWS, including for their strong support and counsel during my first year as CEO and at an important time for the Group. Following the launch of our new strategy in June, we now have our new organisational structure and strengthened management team in place, supported by deep expertise across our Board, as we execute on the growth plan which we have outlined in more detail today."

Β 

For further information, please contact:

RWS Holdings plc

Benjamin Faes, Chief Executive Officer

Β 

01628 410100

Β 

MHP (Financial PR Adviser)

Katie HuntΒ /Β Eleni Menikou

Β 

rws@mhpgroup.com

020 3128 8100

07884 494112

Deutsche Numis (Nominated Adviser & Joint Broker)

Stuart SkinnerΒ /Β William Wickham

Β 

Β 

020 7260 1000

Β 

Berenberg (Joint Broker)

Ben WrightΒ / Toby Flaux /Β Mike BurkeΒ /Β Milo Bonser

Β 

020 3207 7800

Β 

About RWS:

RWS is a global AI solutions company empowering the world's most trusted enterprise AI.

Our proprietary Cultural Intelligence Layer, powered by 250,000 data specialists, cultural and language experts and deep domain professionals, backed by 45+ patents, makes enterprise AI culturally fluent, contextually accurate and secure, ensuring every interaction reflects a brand's tone, context and customer values.

Through our Generate, Transform and Protect segments, we deliver intelligent content, enterprise knowledge, large-scale localisation and IP protection for global growth. Trusted by 80+ of the world's top 100 brands, RWS provides the confidence, governance and expertise organisations need to deploy AI safely, responsibly and at scale.

Headquartered in the UK, RWS is listed on AIM (RWS.L).Β 

For further information, please visit:Β www.rws.com.Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFEAFLLILIE
Date   Source Headline
2nd Oct 202511:38 amRNSHolding(s) in Company
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.